A novel outpatient desensitization protocol for recombinant human erythropoietin allergy in a pediatric patient

BACKGROUND: Recombinant human erythropoietin, such as epoetin alfa and darbepoetin alfa, is an important therapy for anemia due to chronic renal failure. Allergy to recombinant human erythropoietin and the need for desensitization are rare. CASE PRESENTATION: We report here a novel epoetin alfa outp...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosa, Jaime S., Vuong, Van B., Haskin, Orly, Liu, Anne Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846227/
https://www.ncbi.nlm.nih.gov/pubmed/29545827
http://dx.doi.org/10.1186/s13223-018-0233-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846227/
https://www.ncbi.nlm.nih.gov/pubmed/29545827
http://dx.doi.org/10.1186/s13223-018-0233-1

Ejemplares similares